カテゴリー： Market Monitor Global, 世界, 医療/バイオ

小児科用呼吸器科医薬品の世界市場見通し2023年-2029年

◆英語タイトル：Pediatrics Respiratory Drugs Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5882）

◆商品コード：MMG23JU5882
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：72
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Pediatrics Respiratory Drugs Market 調査レポートは次の情報を含め、グローバルにおけるの小児科用呼吸器科医薬品市場規模と予測を収録しています。・世界の小児科用呼吸器科医薬品市場：売上、2018年-2023年、2024年-2029年
・世界の小児科用呼吸器科医薬品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の小児科用呼吸器科医薬品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「粉末吸入」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

小児科用呼吸器科医薬品のグローバル主要企業は、Mylan、 Armstrong Pharmaceuticals、 GlaxoSmithKline、 Valeant Pharmaceuticals、 Merck、 Endo International、 Bauch & Lomb、 Boehringer Ingelheimなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、小児科用呼吸器科医薬品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の小児科用呼吸器科医薬品市場：タイプ別、2018年-2023年、2024年-2029年
世界の小児科用呼吸器科医薬品市場：タイプ別市場シェア、2022年
・粉末吸入、経口

世界の小児科用呼吸器科医薬品市場：用途別、2018年-2023年、2024年-2029年
世界の小児科用呼吸器科医薬品市場：用途別市場シェア、2022年
・病院、診療所、その他

世界の小児科用呼吸器科医薬品市場：地域・国別、2018年-2023年、2024年-2029年
世界の小児科用呼吸器科医薬品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における小児科用呼吸器科医薬品のグローバル売上、2018年-2023年
・主要企業における小児科用呼吸器科医薬品のグローバル売上シェア、2022年
・主要企業における小児科用呼吸器科医薬品のグローバル販売量、2018年-2023年
・主要企業における小児科用呼吸器科医薬品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Mylan、 Armstrong Pharmaceuticals、 GlaxoSmithKline、 Valeant Pharmaceuticals、 Merck、 Endo International、 Bauch & Lomb、 Boehringer Ingelheim

*************************************************************

・調査・分析レポートの概要
小児科用呼吸器科医薬品市場の定義
市場セグメント
世界の小児科用呼吸器科医薬品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の小児科用呼吸器科医薬品市場規模
世界の小児科用呼吸器科医薬品市場規模：2022年 VS 2029年
世界の小児科用呼吸器科医薬品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの小児科用呼吸器科医薬品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の小児科用呼吸器科医薬品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：粉末吸入、経口
小児科用呼吸器科医薬品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、その他
小児科用呼吸器科医薬品の用途別グローバル売上・予測

・地域別市場分析
地域別小児科用呼吸器科医薬品市場規模 2022年と2029年
地域別小児科用呼吸器科医薬品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Mylan、 Armstrong Pharmaceuticals、 GlaxoSmithKline、 Valeant Pharmaceuticals、 Merck、 Endo International、 Bauch & Lomb、 Boehringer Ingelheim
...

Paediatric respiratory medicine (PRM) is a multidisciplinary subspecialty within the specialty of paediatrics, involving doctors, nurses, respiratory physiologists, physiotherapists, the child and the parent/caregiver.
This report aims to provide a comprehensive presentation of the global market for Pediatrics Respiratory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatrics Respiratory Drugs. This report contains market size and forecasts of Pediatrics Respiratory Drugs in global, including the following market information:
Global Pediatrics Respiratory Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Pediatrics Respiratory Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Pediatrics Respiratory Drugs companies in 2022 (%)
The global Pediatrics Respiratory Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Powder Inhalation Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pediatrics Respiratory Drugs include Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline, Valeant Pharmaceuticals, Merck, Endo International, Bauch & Lomb and Boehringer Ingelheim, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatrics Respiratory Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatrics Respiratory Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, by Type, 2022 (%)
Powder Inhalation
Oral
Global Pediatrics Respiratory Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Pediatrics Respiratory Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatrics Respiratory Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pediatrics Respiratory Drugs revenues share in global market, 2022 (%)
Key companies Pediatrics Respiratory Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pediatrics Respiratory Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Armstrong Pharmaceuticals
GlaxoSmithKline
Valeant Pharmaceuticals
Merck
Endo International
Bauch & Lomb
Boehringer Ingelheim
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pediatrics Respiratory Drugs, market overview.
Chapter 2: Global Pediatrics Respiratory Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Pediatrics Respiratory Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pediatrics Respiratory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pediatrics Respiratory Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Pediatrics Respiratory Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pediatrics Respiratory Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pediatrics Respiratory Drugs Overall Market Size
2.1 Global Pediatrics Respiratory Drugs Market Size: 2022 VS 2029
2.2 Global Pediatrics Respiratory Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pediatrics Respiratory Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Pediatrics Respiratory Drugs Players in Global Market
3.2 Top Global Pediatrics Respiratory Drugs Companies Ranked by Revenue
3.3 Global Pediatrics Respiratory Drugs Revenue by Companies
3.4 Global Pediatrics Respiratory Drugs Sales by Companies
3.5 Global Pediatrics Respiratory Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pediatrics Respiratory Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pediatrics Respiratory Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pediatrics Respiratory Drugs Players in Global Market
3.8.1 List of Global Tier 1 Pediatrics Respiratory Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Pediatrics Respiratory Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pediatrics Respiratory Drugs Market Size Markets, 2022 & 2029
4.1.2 Powder Inhalation
4.1.3 Oral
4.2 By Type – Global Pediatrics Respiratory Drugs Revenue & Forecasts
4.2.1 By Type – Global Pediatrics Respiratory Drugs Revenue, 2018-2023
4.2.2 By Type – Global Pediatrics Respiratory Drugs Revenue, 2024-2029
4.2.3 By Type – Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Pediatrics Respiratory Drugs Sales & Forecasts
4.3.1 By Type – Global Pediatrics Respiratory Drugs Sales, 2018-2023
4.3.2 By Type – Global Pediatrics Respiratory Drugs Sales, 2024-2029
4.3.3 By Type – Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Pediatrics Respiratory Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pediatrics Respiratory Drugs Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Pediatrics Respiratory Drugs Revenue & Forecasts
5.2.1 By Application – Global Pediatrics Respiratory Drugs Revenue, 2018-2023
5.2.2 By Application – Global Pediatrics Respiratory Drugs Revenue, 2024-2029
5.2.3 By Application – Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Pediatrics Respiratory Drugs Sales & Forecasts
5.3.1 By Application – Global Pediatrics Respiratory Drugs Sales, 2018-2023
5.3.2 By Application – Global Pediatrics Respiratory Drugs Sales, 2024-2029
5.3.3 By Application – Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Pediatrics Respiratory Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pediatrics Respiratory Drugs Market Size, 2022 & 2029
6.2 By Region – Global Pediatrics Respiratory Drugs Revenue & Forecasts
6.2.1 By Region – Global Pediatrics Respiratory Drugs Revenue, 2018-2023
6.2.2 By Region – Global Pediatrics Respiratory Drugs Revenue, 2024-2029
6.2.3 By Region – Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Pediatrics Respiratory Drugs Sales & Forecasts
6.3.1 By Region – Global Pediatrics Respiratory Drugs Sales, 2018-2023
6.3.2 By Region – Global Pediatrics Respiratory Drugs Sales, 2024-2029
6.3.3 By Region – Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pediatrics Respiratory Drugs Revenue, 2018-2029
6.4.2 By Country – North America Pediatrics Respiratory Drugs Sales, 2018-2029
6.4.3 US Pediatrics Respiratory Drugs Market Size, 2018-2029
6.4.4 Canada Pediatrics Respiratory Drugs Market Size, 2018-2029
6.4.5 Mexico Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pediatrics Respiratory Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Pediatrics Respiratory Drugs Sales, 2018-2029
6.5.3 Germany Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.4 France Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.5 U.K. Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.6 Italy Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.7 Russia Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Pediatrics Respiratory Drugs Market Size, 2018-2029
6.5.9 Benelux Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pediatrics Respiratory Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Pediatrics Respiratory Drugs Sales, 2018-2029
6.6.3 China Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6.4 Japan Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6.5 South Korea Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Pediatrics Respiratory Drugs Market Size, 2018-2029
6.6.7 India Pediatrics Respiratory Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pediatrics Respiratory Drugs Revenue, 2018-2029
6.7.2 By Country – South America Pediatrics Respiratory Drugs Sales, 2018-2029
6.7.3 Brazil Pediatrics Respiratory Drugs Market Size, 2018-2029
6.7.4 Argentina Pediatrics Respiratory Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pediatrics Respiratory Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pediatrics Respiratory Drugs Sales, 2018-2029
6.8.3 Turkey Pediatrics Respiratory Drugs Market Size, 2018-2029
6.8.4 Israel Pediatrics Respiratory Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Pediatrics Respiratory Drugs Market Size, 2018-2029
6.8.6 UAE Pediatrics Respiratory Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Mylan
7.1.1 Mylan Company Summary
7.1.2 Mylan Business Overview
7.1.3 Mylan Pediatrics Respiratory Drugs Major Product Offerings
7.1.4 Mylan Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Mylan Key News & Latest Developments
7.2 Armstrong Pharmaceuticals
7.2.1 Armstrong Pharmaceuticals Company Summary
7.2.2 Armstrong Pharmaceuticals Business Overview
7.2.3 Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Major Product Offerings
7.2.4 Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Armstrong Pharmaceuticals Key News & Latest Developments
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Company Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Pediatrics Respiratory Drugs Major Product Offerings
7.3.4 GlaxoSmithKline Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.3.5 GlaxoSmithKline Key News & Latest Developments
7.4 Valeant Pharmaceuticals
7.4.1 Valeant Pharmaceuticals Company Summary
7.4.2 Valeant Pharmaceuticals Business Overview
7.4.3 Valeant Pharmaceuticals Pediatrics Respiratory Drugs Major Product Offerings
7.4.4 Valeant Pharmaceuticals Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Valeant Pharmaceuticals Key News & Latest Developments
7.5 Merck
7.5.1 Merck Company Summary
7.5.2 Merck Business Overview
7.5.3 Merck Pediatrics Respiratory Drugs Major Product Offerings
7.5.4 Merck Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Merck Key News & Latest Developments
7.6 Endo International
7.6.1 Endo International Company Summary
7.6.2 Endo International Business Overview
7.6.3 Endo International Pediatrics Respiratory Drugs Major Product Offerings
7.6.4 Endo International Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Endo International Key News & Latest Developments
7.7 Bauch & Lomb
7.7.1 Bauch & Lomb Company Summary
7.7.2 Bauch & Lomb Business Overview
7.7.3 Bauch & Lomb Pediatrics Respiratory Drugs Major Product Offerings
7.7.4 Bauch & Lomb Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Bauch & Lomb Key News & Latest Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Company Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Pediatrics Respiratory Drugs Major Product Offerings
7.8.4 Boehringer Ingelheim Pediatrics Respiratory Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Boehringer Ingelheim Key News & Latest Developments
8 Global Pediatrics Respiratory Drugs Production Capacity, Analysis
8.1 Global Pediatrics Respiratory Drugs Production Capacity, 2018-2029
8.2 Pediatrics Respiratory Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Pediatrics Respiratory Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pediatrics Respiratory Drugs Supply Chain Analysis
10.1 Pediatrics Respiratory Drugs Industry Value Chain
10.2 Pediatrics Respiratory Drugs Upstream Market
10.3 Pediatrics Respiratory Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pediatrics Respiratory Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Pediatrics Respiratory Drugs in Global Market
Table 2. Top Pediatrics Respiratory Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pediatrics Respiratory Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pediatrics Respiratory Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Pediatrics Respiratory Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Pediatrics Respiratory Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pediatrics Respiratory Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Pediatrics Respiratory Drugs Product Type
Table 9. List of Global Tier 1 Pediatrics Respiratory Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatrics Respiratory Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Pediatrics Respiratory Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pediatrics Respiratory Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Pediatrics Respiratory Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Pediatrics Respiratory Drugs Sales (K Units), 2024-2029
Table 16. By Application – Global Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Pediatrics Respiratory Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pediatrics Respiratory Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Pediatrics Respiratory Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Pediatrics Respiratory Drugs Sales (K Units), 2024-2029
Table 21. By Region – Global Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Pediatrics Respiratory Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pediatrics Respiratory Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Pediatrics Respiratory Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Pediatrics Respiratory Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Pediatrics Respiratory Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Pediatrics Respiratory Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Pediatrics Respiratory Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Pediatrics Respiratory Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Pediatrics Respiratory Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Pediatrics Respiratory Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Pediatrics Respiratory Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Pediatrics Respiratory Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Pediatrics Respiratory Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Pediatrics Respiratory Drugs Sales, (K Units), 2024-2029
Table 46. Mylan Company Summary
Table 47. Mylan Pediatrics Respiratory Drugs Product Offerings
Table 48. Mylan Pediatrics Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Mylan Key News & Latest Developments
Table 50. Armstrong Pharmaceuticals Company Summary
Table 51. Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Product Offerings
Table 52. Armstrong Pharmaceuticals Pediatrics Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Armstrong Pharmaceuticals Key News & Latest Developments
Table 54. GlaxoSmithKline Company Summary
Table 55. GlaxoSmithKline Pediatrics Respiratory Drugs Product Offerings
Table 56. GlaxoSmithKline Pediatrics Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. GlaxoSmithKline Key News & Latest Developments
Table 58. Valeant Pharmaceuticals Company Summary
Table 59. Valeant Pharmaceuticals Pediatrics Respiratory Drugs Product Offerings
Table 60. Valeant Pharmaceuticals Pediatrics Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Valeant Pharmaceuticals Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Pediatrics Respiratory Drugs Product Offerings
Table 64. Merck Pediatrics Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Endo International Company Summary
Table 67. Endo International Pediatrics Respiratory Drugs Product Offerings
Table 68. Endo International Pediatrics Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Endo International Key News & Latest Developments
Table 70. Bauch & Lomb Company Summary
Table 71. Bauch & Lomb Pediatrics Respiratory Drugs Product Offerings
Table 72. Bauch & Lomb Pediatrics Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Bauch & Lomb Key News & Latest Developments
Table 74. Boehringer Ingelheim Company Summary
Table 75. Boehringer Ingelheim Pediatrics Respiratory Drugs Product Offerings
Table 76. Boehringer Ingelheim Pediatrics Respiratory Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Boehringer Ingelheim Key News & Latest Developments
Table 78. Pediatrics Respiratory Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Pediatrics Respiratory Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Pediatrics Respiratory Drugs Production by Region, 2018-2023 (K Units)
Table 81. Global Pediatrics Respiratory Drugs Production by Region, 2024-2029 (K Units)
Table 82. Pediatrics Respiratory Drugs Market Opportunities & Trends in Global Market
Table 83. Pediatrics Respiratory Drugs Market Drivers in Global Market
Table 84. Pediatrics Respiratory Drugs Market Restraints in Global Market
Table 85. Pediatrics Respiratory Drugs Raw Materials
Table 86. Pediatrics Respiratory Drugs Raw Materials Suppliers in Global Market
Table 87. Typical Pediatrics Respiratory Drugs Downstream
Table 88. Pediatrics Respiratory Drugs Downstream Clients in Global Market
Table 89. Pediatrics Respiratory Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pediatrics Respiratory Drugs Segment by Type in 2022
Figure 2. Pediatrics Respiratory Drugs Segment by Application in 2022
Figure 3. Global Pediatrics Respiratory Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pediatrics Respiratory Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pediatrics Respiratory Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Pediatrics Respiratory Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pediatrics Respiratory Drugs Revenue in 2022
Figure 9. By Type - Global Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Pediatrics Respiratory Drugs Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Pediatrics Respiratory Drugs Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Pediatrics Respiratory Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
Figure 23. US Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
Figure 28. Germany Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
Figure 37. China Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Pediatrics Respiratory Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Pediatrics Respiratory Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Pediatrics Respiratory Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Pediatrics Respiratory Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Pediatrics Respiratory Drugs by Region, 2022 VS 2029
Figure 54. Pediatrics Respiratory Drugs Industry Value Chain
Figure 55. Marketing Channels

※参考情報

小児科用呼吸器科医薬品は、小児の呼吸器疾患の治療に使用される薬剤を指します。小児と成人では生理的、解剖学的な違いがあるため、特に小児向けに調整された薬品が必要です。これらの薬剤は、小児特有の症状や疾患を考慮し、使用されます。

小児科用呼吸器科医薬品の特徴として、まず小児の体重や年齢に基づいた用量調整が挙げられます。成人に比べて小児の体は小さく、代謝や排泄の速度も異なるため、過剰な投与を避けるための細やかな配慮が必要です。また、小児向け製剤は、飲みやすさや使いやすさも考慮され、シロップ、吸入剤、スプレーなど多様な形態が用意されています。さらに、小児は成人に比べて副作用やアレルギー反応が出やすいことから、安全性が特に重視されます。

小児科用呼吸器科医薬品は、主に以下のような種類に分類されます。まずは抗アレルギー薬です。これらはアレルギー性鼻炎や喘息の治療に用いられ、ヒスタミンの作用を抑えることで、症状を軽減します。次に、気管支拡張薬があります。これらは喘息や慢性閉塞性肺疾患の発作時に呼吸を楽にするために使用されます。短時間作用型と長時間作用型のものがあり、使用方法により選択がなされます。

さらに、ステロイド薬も小児科用呼吸器科医薬品として重要です。これらは主に炎症を抑える効果があり、重症喘息や慢性肺疾患の管理に役立ちます。吸入ステロイド薬は特に小児において効果が高く、全身性の副作用を抑えながら局所での効果を発揮します。また、抗生物質も呼吸器感染症の治療に用いられます。小児は特に細菌感染にかかりやすいため、適切な抗菌療法が必要です。

用途としては、喘息、アレルギー性鼻炎、慢性閉塞性肺疾患、気管支炎、肺炎などが含まれます。喘息は特に多くの小児に見られる疾患であり、適切な薬剤を使用することで発作のコントロールが可能となります。アレルギー性鼻炎は季節性や通年性があり、これも小児に多く、抗アレルギー薬が有効です。慢性閉塞性肺疾患は主に成人に見られますが、重度の小児の場合には気管支拡張薬やステロイド薬が必要となります。

関連技術としては、吸入療法の進歩があります。吸入器の技術は年々進化しており、特に小児用には使いやすいデザインが増えています。乾燥粉末吸入器（DPI）やメッシュ式吸入器など、肺に直接薬剤を届ける方法が多様化しています。また、エビデンスに基づいた治療法の確立も進んでおり、小児科医は最新の研究結果をもとに治療法を選択しています。さらに、在宅での管理が進む中、家庭で使用できる器具やアプリも登場しています。これにより小児の健康状態をリアルタイムでモニタリングできるようになり、保護者も安心して管理できる環境が整いつつあります。

小児科用呼吸器科医薬品は、急性疾患の治療に留まらず、慢性疾患の管理にも重要な役割を果たします。服用方法、用量、期待される効果、副作用の管理など、細心の注意を払う必要があります。また、医療者と保護者のコミュニケーションが治療の成功に不可欠であり、医療者は保護者に適切な情報を提供し、理解を得ることが求められます。

小児における呼吸器疾患は多岐にわたりますが、適切な医薬品と治療法の選択が、早期の回復や健康な成長に寄与します。小児科用呼吸器科医薬品を効果的に活用することで、親子の生活の質を向上させることが可能です。今後、技術の進化と共に、より安全で効果的な医薬品の開発が期待され、さらに多くの小児が健康でいられる社会を目指した取り組みが続けられることでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 小児科用呼吸器科医薬品の世界市場見通し2023年-2029年(Pediatrics Respiratory Drugs Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

小児科用呼吸器科医薬品の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp